Stock Data
$2.49 (5.09%)
Asset Type
N/A
Exchange
N/A
Currency
N/A
Country
N/A
Sector
N/A
Industry
N/A
AxoGen, Inc. specializes in innovative technologies for the regeneration and repair of peripheral nerves. With a focus on improving quality of life, its product lineup includes the Avance Nerve Graft for bridging severed nerves, AxoGuard Nerve Connector for tensionless repair, and AxoGuard Nerve Protector to wrap and safeguard damaged nerves. Additionally, AxoGen offers the Axoguard Nerve Cap to protect nerve ends and the AxoTouch for assessing skin innervation. Serving hospitals and surgeons across the globe, AxoGen is a leader in its field, headquartered in Alachua, Florida.
Axogen topped both earnings and revenue expectations while lifting full-year guidance on the back of explosive 50%+ growth in its Breast segment, a shift that's now reshaping the company's revenue mix and fueling a 23% year-over-year sales jump.
0 Articles
No articles found for Axogen.
Live News & Earnings
Our top personal finance-related articles today. Your wallet will thank you later.
